Department of Pediatrics, Örebro University Hospital, Örebro, Sweden.
Department of Pediatrics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Front Endocrinol (Lausanne). 2020 Nov 17;11:584906. doi: 10.3389/fendo.2020.584906. eCollection 2020.
A growth hormone (GH) stimulation test is the recommended method for evaluating GH levels in children with possible GH deficiency (GHD). However, serial measurements of nocturnal spontaneous GH secretion are also performed. Divergent results from these tests have been reported, but with variable frequencies.
To investigate whether performing one or two GH tests is associated with the probability to diagnose a child with GHD; the frequency of divergent results in the arginine-insulin tolerance test (AITT) and the nocturnal spontaneous test using different cut-off levels, and whether refractoriness may explain some of the discordance.
In a population-based setting, the medical records of all short children evaluated for possible GHD during January 1993-February 2017 were reviewed. Twenty-one patients had been evaluated with one GH test only and 102 children had been evaluated with a spontaneous nocturnal GH test followed immediately by a complete AITT. Divergent results were defined as having a pathological response on only one of the tests when using 3, 5, 7, and 10 µg/L as cut-offs for peak GH on both tests, 1.1 and 3.3 µg/L for mean nocturnal values and receiver operating characteristic curves-derived cut-offs for nocturnal values.
Children evaluated with one test only were more often diagnosed with GHD compared with children evaluated with both tests (48 vs. 19%, p = 0.019). Divergent results were found in 6-42% of the patients, with higher frequencies seen when higher cut-offs were applied. A higher proportion of patients with stimulated peak values ≤ 7 and ≤ 5 µg/L had a spontaneous peak within 2 h before the start of the AITT compared with patients with higher stimulated peak values (68 vs. 45%, p = 0.026, and 77 vs. 48%, p = 0.033, respectively).
Divergent results between AITT and nocturnal spontaneous secretion are common in short children, dependent on the cut-offs applied and partly due to refractoriness. Performing both tests decreases the risk of over diagnosing GHD in short children.
生长激素(GH)刺激试验是评估疑似生长激素缺乏症(GHD)儿童 GH 水平的推荐方法。然而,也会进行夜间自发性 GH 分泌的连续测量。这些测试的结果存在差异,但频率不同。
研究进行一次或两次 GH 测试是否与诊断 GHD 儿童的可能性相关;使用不同截断值的精氨酸-胰岛素耐量试验(AITT)和夜间自发性试验中出现不一致结果的频率,以及是否存在抵抗性可能解释一些不一致性。
在基于人群的环境中,回顾了 1993 年 1 月至 2017 年 2 月期间所有因疑似 GHD 接受评估的矮小儿童的病历。21 例患者仅接受一次 GH 测试评估,102 例患者接受夜间自发性 GH 测试,随后立即进行完整的 AITT。不一致的结果定义为仅在使用 3、5、7 和 10 µg/L 作为两个测试的 GH 峰值截断值时,在仅一个测试中出现病理性反应,而在两个测试中使用 1.1 和 3.3 µg/L 作为平均夜间值的截断值和基于接收者操作特征曲线的夜间值截断值。
仅接受一次测试评估的儿童被诊断为 GHD 的比例高于接受两次测试评估的儿童(48%比 19%,p = 0.019)。在 6-42%的患者中发现不一致的结果,使用较高的截断值时频率更高。与具有较高刺激峰值值≤7 和≤5 µg/L 的患者相比,在 AITT 开始前 2 小时内具有自发性峰值的患者比例更高(68%比 45%,p = 0.026,和 77%比 48%,p = 0.033,分别)。
在矮小儿童中,AITT 和夜间自发性分泌之间的不一致结果很常见,这取决于所应用的截断值,部分原因是抵抗性。同时进行两项测试可降低矮小儿童过度诊断 GHD 的风险。